Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00881712 · ClinicalTrials.gov registry record · NA
Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00881712: Clinical Trial NA study, sponsored by University of Florida.
NCT00881712 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00881712, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what effects, good and/or bad, proton radiation at a higher tumor dose (and lower normal surrounding lung dose) combined with standard chemotherapy has on lung cancer. The dose you receive to the tumor will be higher than the standard dose. This may be able to increase the control of the tumor. Due to the accuracy of radiation given with protons, the dose to the normal lung tissue that surrounds the tumor will be lower than standard. This may be able to reduce the frequency and severity of the usual radiation side effects.
Interventions
- RADIATION PET positive nodal disease measuring 15 mm or greater
- RADIATION PET positive nodal disease measuring less than 15 mm
- RADIATION Patients considered resectable
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-10 |
| Phase | NA |
Why NCT00881712 stopped before completion
NCT00881712 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which PET positive nodal disease measuring 15 mm or greater is the first listed.
NCT00881712 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00881712 about?
NCT00881712 is a clinical study titled "Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)". The purpose of this study is to find out what effects, good and/or bad, proton radiation at a higher tumor dose (and lower normal surrounding lung dose) combined with standard chemotherapy has on lung cancer. The dose you receive to the tumor will be higher than the standard dose. This may be able t...
What is the current status of trial NCT00881712?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2009-06. Estimated completion is 2014-10.
What interventions are being tested in trial NCT00881712?
The interventions under investigation include: PET positive nodal disease measuring 15 mm or greater (RADIATION), PET positive nodal disease measuring less than 15 mm (RADIATION), Patients considered resectable (RADIATION).
Who is sponsoring clinical trial NCT00881712?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00881712's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia